Diabetes News and Research

Latest Diabetes News and Research

Racial disparities exist among living kidney donors, post donation: Research

Black and Hispanic kidney donors are significantly more likely than white donors to develop hypertension, diabetes and chronic kidney disease, according to new Saint Louis University research published in the August 19, 2010 issue of the New England Journal of Medicine.

20 Aug 2010

Report: Diabetes costs account for nearly a quarter of all hospital spending

The Fiscal Times examines a recent report from the Agency for Healthcare Research and Quality about diabetes, "a disease that's costing Americans $83 billion a year in hospital fees—23 percent of total hospital spending. ... Add to this the costs of the hidden diabetes epidemic: $18 billion for the estimated 6.3 million people with undiagnosed diabetes, and $25 billion for 57 million, or one in four, American adults with pre-diabetes.

20 Aug 2010

FDA Advisory Committee votes in favor of expanding pain indications for Eli Lilly's Cymbalta

The U.S. Food and Drug Administration (FDA) Anesthetic and Life Support Drugs Advisory Committee voted 8-6 in favor of expanding the pain indications for Eli Lilly and Company's (NYSE: LLY) Cymbalta® (duloxetine HCl) to a broader pain population that will be further defined by the FDA, if approved.

20 Aug 2010

Renin test can predict appropriate drugs for BP patients: Study

Commonly prescribed drugs used to lower blood pressure can actually have the opposite effect-raising blood pressure in a statistically significant percentage of patients. A new study by researchers at Albert Einstein College of Medicine of Yeshiva University suggests that doctors could avoid this problem-and select drugs most suitable for their patients-by measuring blood levels of the enzyme renin through a blood test that is becoming more widely available. The study appears in the online edition of the American Journal of Hypertension.

20 Aug 2010

USPTO rules out Oculir's claim on noninvasive glucose measuring device patent

The U.S. Patent and Trademark Office (USPTO) has held that all claims in Oculir's Patent No. 6,958,039 to be invalid as not patentable based on prior art from a patent disclosure by Yale researcher, Dr. Marc Abreu.

20 Aug 2010

Study on multisensory processing in autistic children

A new study by researchers at Albert Einstein College of Medicine of Yeshiva University has provided concrete evidence that children with autism spectrum disorders (ASD) process sensory information such as sound, touch and vision differently than typically developing children.

20 Aug 2010

Intake of green leafy vegetables reduces risk of developing type 2 diabetes

Eating more green leafy vegetables can significantly reduce the risk of developing type 2 diabetes, finds research published today on bmj.com.

20 Aug 2010

New ways to tackle diabetes

According to a new analysis from UK, a diet rich in green leafy vegetables may reduce the risk of developing diabetes. The inference was drawn from six studies which looked into fruit and vegetable intake and found that only food including spinach and cabbage was found to have a significant positive effect. The findings were published in the British Medical Journal (BMJ).

19 Aug 2010

Emunamedica licenses technology for near-infrared wound monitor from Drexel University

Patients with diabetes-associated wounds could receive faster and more effective treatment thanks to a non-invasive device that monitors wound healing and is one step closer to market. Emunamedica LLC, a Florida-based healthcare start-up, has licensed technology for a near-infrared wound monitor from Drexel University. The device was developed by Dr. Elisabeth Papazoglou and Dr. Leonid Zubkov of Drexel's School of Biomedical Engineering, Science and Health Systems in collaboration with Dr. Michael S. Weingarten, M.D. of Drexel College of Medicine and their teams.

19 Aug 2010

Study finds burnout progressively develops among medical students

More than 40 percent of third-year medical students have symptoms of moderate to severe burnout, according to a study in the August Southern Medical Journal, official journal of the Southern Medical Association.

19 Aug 2010

Discovery on stem cell can create new opportunity in organ regeneration field

Taking one type of cell and transforming it into another type is now possible. Cells taken from the thymus have been transformed into skin cells,a discovery that may have important ramifications for the field of organ regeneration.

19 Aug 2010

New clues to molecular action of Alzheimer's drug memantine

Alzheimer's disease destroys brain cells and their connections (called synapses), causing memory loss and other cognitive problems that disrupt work, hobbies and daily life. Symptoms can be alleviated, in part, by the drug memantine (marketed in the United States as Namenda), which is currently FDA-approved to treat moderate-to-severe Alzheimer's disease and was, in part, developed by Stuart A. Lipton, M.D., Ph.D., Director of the Del E. Web Center for Neuroscience, Aging and Stem Cell Research at Sanford-Burnham Medical Research Institute (Sanford-Burnham).

19 Aug 2010

Podiatrist reduces leg amputation risk in diabetics: Study

People with diabetic foot problems can lower their risk of leg amputation by relying on coordinated care that includes a podiatrist, according to a recent study. For instance, those with diabetes-related foot ulcers can reduce their risk of amputation by 31 percent.

19 Aug 2010

U.S. children and adolescents become fatter over the last decade: Study

Overweight American children and adolescents have become fatter over the last decade, according to researchers at the Johns Hopkins Bloomberg School of Public Health and National Institute on Aging (NIA). They examined adiposity shifts across socio-demographic groups over time and found U.S. children and adolescents had significantly increased adiposity measures such as body mass index (BMI), waist circumference (WC) and triceps skinfold thickness (TST).

19 Aug 2010

New 'Pesticide-Induced Diseases Database' tracks published epidemiologic and real world exposure studies

Links to pesticide exposure are being found in a growing number of studies that evaluate the causes of preventable diseases -- including asthma, autism and learning disabilities, birth defects and reproductive dysfunction, diabetes, Parkinson's and Alzheimer's diseases, and several types of cancer. A new database, released today, tracks published epidemiologic and real world exposure studies.

19 Aug 2010

Broadband could be boon for rural clinics

A federal broadband initiative may have implications for the health system, too, NPR reports. "Millions of Americans who live in rural areas travel long distances to get health care. Or they may go without it. But high-speed Internet connections now make it possible to bring a doctor's expertise to patients in far-off places, if those places are connected. As part of its National Broadband Plan, the Federal Communications Commission has pledged $400 million a year to connect nearly 12,000 rural health care providers."

19 Aug 2010

70% rise in kidney disease in Australia over past 7 years: Report

According to a report released today by the Australian Institute of Health and Welfare (AIHW), with the rise of type II diabetes patients, there is increasing number of hospitalizations related to chronic kidney disease in Australia.

18 Aug 2010

Wound Management Technologies' CellerateRX introduced at DFWG congress in South Africa

Wound Management Technologies, Inc. announced today that its new international distributor, Spiramed (Pty) Ltd, exhibited its advanced wound care collagen product, CellerateRX® last weekend at the DFWG (Diabetic Foot Working Group) congress in Cape Town and has already planned exhibitions at two additional upcoming conferences. This second meeting of the DFWG congress was attended by over 120 diabetic foot specialists.

18 Aug 2010

XOMA sells royalty interest in CIMZIA

XOMA Ltd., a leader in the discovery and development of therapeutic antibodies, announced today that it has sold its royalty interest in CIMZIA® (certolizumab pegol) marketed by UCB S.A. for $4 million to an undisclosed buyer. The manufacture of CIMZIA is covered by a license to XOMA's Bacterial Cell Expression technology.

18 Aug 2010

Hospitals should inform patients about availability of insurance coverage for breast reconstruction: New law

While breast reconstruction after a mastectomy is covered by insurers in New York, many poor, minority, and less educated women do not seek out the procedure. Now, NY Gov. David A. Paterson has signed into law a bill that is aimed at reversing this trend.

18 Aug 2010